Stellar-NP
Advanced Nasal Vaccine Platform
The Stellar-NP platform is an advanced antigen delivery technology designed to enhance the immune response of prophylactic vaccines and enable therapeutic ones. Proof of concept has been established against fungi, parasites, viruses, and bacteria.
We are committed to a One Health approach.
Vaxinano is a clinical stage Biotech company, founded by experts in biotech, vaccine and delivery systems.
Founded in 2016, the company was created by Pr. Didier Betbeder and develops best-in-class delivery systems and vaccines to adress urgent needs in the treatment of veterinary and human infectious diseases.
Vaxinano commits to support endangered and threatened species through partnerships with Zoos.
Since 2017, vaccination campaigns have been carried out in 32 zoos around the world. More than 10,000 animals including thousands of primates have been vaccinated against lethal toxoplasmosis, stopping annual outbreaks that previously killed up 30% of some endagered captive wild species in these zoos.
